Pep-Back ReCharge Interactions
There are 109 drugs known to interact with Pep-Back ReCharge (caffeine), along with 9 disease interactions, and 5 alcohol/food interactions. Of the total drug interactions, 5 are major, 89 are moderate, and 15 are minor.
- View Pep-Back ReCharge alcohol/food interactions (5)
- View Pep-Back ReCharge disease interactions (9)
Medications known to interact with Pep-Back ReCharge
Note: Showing generic names only.
- abametapir topical
- adenosine
- albuterol
- alosetron
- aminophylline
- amphetamine
- anagrelide
- arformoterol
- armodafinil
- aspirin
- atazanavir
- atomoxetine
- deferasirox
- dexmethylphenidate
- dextroamphetamine
- diazepam
- diethylpropion
- dipyridamole
- disulfiram
- dobutamine
- dopamine
- doxapram
- duloxetine
- ma huang
- mazindol
- melatonin
- mephentermine
- metaproterenol
- metaraminol
- methamphetamine
- methotrexate
- methoxamine
- methylphenidate
- mibefradil
- modafinil
- pacritinib
- phendimetrazine
- phentermine
- phenylephrine
- phenylpropanolamine
- pimozide
- pirbuterol
- pseudoephedrine
- racepinephrine
- ramelteon
- rasagiline
- regadenoson
- riluzole
- ritlecitinib
- ritodrine
- ropinirole
- ropivacaine
- rucaparib
- terbinafine
- terbutaline
- teriflunomide
- theophylline
- thiabendazole
- tirzepatide
- tizanidine
- topotecan
- trovafloxacin
Pep-Back ReCharge alcohol/food interactions
There are 5 alcohol/food interactions with Pep-Back ReCharge (caffeine).
Pep-Back ReCharge disease interactions
There are 9 disease interactions with Pep-Back ReCharge (caffeine) which include:
- cardiac disease
- hypertension
- psychiatric disorders
- PUD
- cardiotoxicity
- liver disease
- renal dysfunction
- seizure disorders
- GERD
More about Pep-Back ReCharge (caffeine)
- Pep-Back ReCharge consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: CNS stimulants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.